Study Explores Link Between Opioid Prescribing And Overdose Deaths
A new study uses Massachusetts to look at whether there's a correlation between suspicious prescribing behavior and opioid overdose deaths.
View ArticleAs Health Care Costs Soar, State Legislators Focus On Price-Control Techniques
Lawmakers on Beacon Hill are zeroing in on prescription drug prices as part of their latest attempt to rein in high health care costs.
View ArticleHarvard Study On Workplace Wellness: Behaviors Change But Health Does Not —...
Researchers followed more than 30,000 employees at BJ's warehouses.
View ArticleHouse GOP Leader Seeks Debate On Opioid, Vaping Taxes
Republican Gov. Charlie Baker originally asked for the 15 percent tax as part of his state budget request in January, but it was not included in a spending plan released last week.
View Article71-Year-Old Heart Study Gets $38 Million Grant For Another 6 Years
The nation's longest-running multigenerational study of cardiovascular disease has received a $38 million grant that will help researchers explore the biology of aging.
View ArticleNew Genetic 'Score' Can Predict Risk For Obesity, Study Says
A new study uses genetic testing to assess a person's obesity risk.
View ArticleUrgent Care On Demand, Except This Time For Mental Health
"Sometimes you just need a quick look to see if there's something that can be done in the moment that might get you back on track for your care," says Dr. David Kroll, a psychiatrist at Brigham and...
View ArticleMass. Researchers Receive $89 Million To Combat Opioid Overdose Deaths
The goal of the federal grant is to reduce overdose deaths by 40% in 3 years and create national models to curb the opioid epidemic.
View ArticleStudy Finds Signs Of Bacteria And Fungi In Many Vaping Products
Nearly a quarter of popular high-nicotine products showed signs of bacterial contamination, one more "buyer beware" about vaping, researchers say.
View ArticleHow OxyContin's Maker Sought To Influence Mass. Legislators
From 2004 to 2018, Purdue Pharma paid lobbyists in Massachusetts a total of $886,000 to protect its drugs.
View ArticleArlene Sharpe's Science Helps Cancer Patients, And 'It Doesn't Get Better...
The chair of Harvard's new immunology department helped pioneer the science behind the most promising new type of cancer treatment in decades -- and it all began with lima beans in the living room.
View ArticleDEA Encourages New England Residents To Take Advantage Of National Drug...
The public can dispose of expired, unused or unwanted prescription medications at more than 600 collection sites across the region on Saturday.
View ArticleJurors To Resume Lengthy Deliberations In Opioid Bribes Case
Jurors will begin their 12th day of deliberations on Monday in the case against Insys Therapeutics Founder John Kapoor and four other former executives of the Chandler, Arizona-based company.
View ArticleYou're Invited: 5/1 WBUR Evening With Wunderkind CRISPR Scientists
Join Morning Edition producer Khari Thompson for an inspiring "Ask Me Anything" with two leading young CRISPR scientists from MIT's McGovern Institute.
View ArticleNortheastern Public Health Institute Sues JUUL Over Marketing Nicotine To Minors
Mark Gottlieb is the executive director of the Public Health Advocacy Institute at Northeastern. He joined WBUR's Morning Edition host Jack Lepiarz to talk about the threatened lawsuit.
View ArticleMarijuana Investor Gives $9 Million To Harvard And MIT For Cannabis Science
The donation from financier Bob Broderick will help fill what's widely seen as an urgent need for solid research on how cannabis affects the brain.
View ArticleIn His Book, 'Well,' BU Public Health Dean Urges A Collective Approach To Health
Dr. Sandro Galea explores in his new book how he thinks we need to change the way we talk about, and thereby improve, the nation's health.
View ArticleSome Boston Doctors Bring Climate Change Into The Exam Room — Warily
A very small but growing number of doctors and nurses are discussing the consequences of climate change with patients, in the exam room.
View ArticleOpioid Drug Company Founder Found Guilty In Bribery Scheme
John Kapoor, the founder of Insys Therapeutics, was found guilty of racketeering conspiracy after 15 days of deliberations. The case threw a spotlight on the government's efforts to go after those it...
View ArticleJury Finds Executives In Insys Therapeutics Trial Guilty Of Racketeering...
Aaron Leibowitz weighs in on the significance of the verdicts in the Insys trial.
View Article